Source: International Congress 2018 – Biomarkers and lung function in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Ramsey (Chapel Hill, United States of America), G. Radicioni (Chapel Hill, United States of America), D. Hill (Chapel Hill, United States of America), C. Ehre (Chapel Hill, United States of America), B. Button (Chapel Hill, United States of America), N. Alexis (Chapel Hill, United States of America), M. Knowles (Chapel Hill, United States of America), S. Donaldson (Chapel Hill, United States of America), M. Kesimer (Chapel Hill, United States of America), M. Mcguckin (Brisbane, Australia), R. Boucher (Chapel Hill, United States of America). Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis. 5049

Member's Comments

No comment yet.

Related content which might interest you: The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 181-198 Year: 2017 Immuno-allertypes in non-cystic fibrosis  bronchiectasis Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Non-cystic fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020 Non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2017; 77: 38-57 Year: 2017 Non-cystic fibrosis bronchiectasis Source: International Congress 2019 – Recent clinical advances in inhalation therapy Year: 2019 Non-cystic fibrosis bronchiectasis in children Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021 The pulmonary microbiome in non-cystic fibrosis bronchiectasis. Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Management and prevention of non-cystic fibrosis bronchiectasis Source: International Congress 2015 – PG9 Lower respiratory tract infection in children Year: 2015 Airway inflammation in cystic fibrosis Source: Eur Respir Monogr 2014; 64: 14-31 Year: 2014 Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018 HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis. Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Cystic fibrosis fibrosis bronchiectasis Source: Virtual Congress 2020 – Paediatric year in review Year: 2020 Diagnosing bronchiectasis and cystic fibrosis Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis Year: 2018 Arginase in patients with cystic fibrosis airway disease Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004 NTM in cystic fibrosis and non-CF bronchiectasis Source: ERS Course 2015 Year: 2015 Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018 Cystic fibrosis severity and bronchial hyperresponsiveness Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 Airways reflux contributes to cough severity and airways inflammation in non-CF bronchiectasis Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011